Biomedicum Genomics (BMGen) provides academic and industrial clients
access to a wide range of functional genomics technologies, services and
partnering solutions.
Our core technologies include genome-wide expression, copy number
profiling, miRNA expression, DNA-protein interaction (ChIP-on-chip),
Illumina high-throughput sequencing including nucleic acid quality and
quantity assessment. For gene silencing and ectopic expression purposes,
we offer high-titer shRNA and ORF lentiviruses targeting genes of
interest.
We also offer customized services e.g.
preparation of gain or loss-of-function cell lines and protein
interactomics-based services (yeast two-hybrid). In addition, we provide
access to wide array of computational data analyses. BMGen also offers
partnering deals for clients interested in
customized integration of several technologies.
|
